Research Presentation Sessions: Oncologic Imaging
RPS 2116 - Gastrointestinal tumours
Lectures
1
Introduction by the moderator
02:00Sofia Gourtsoyianni, Athens / GR
2
Clinical impact of MRI compared to 68Ga-DOTATATE PET-CT in monitoring metastasised neuroendocrine tumours (NETs): can MRI replace 68Ga-DOTATATE PET-CT?
08:00Charlotte Rijsemus, Amsterdam / NL
3
Contrast-enhanced computed tomography texture analysis in colon cancer: correlation with genetic markers
08:00Giulio Cabrelle, Padua / IT
4
Whether quantitative spectral parameters can predict lymph node metastasis in colorectal cancer: a preliminary study
08:00Wenjing Peng, Beijing / CN
5
A new standard for monitoring treatment response after neoadjuvant chemotherapy in colorectal cancer patients with peritoneal metastases: 'the estimated volume index' (EVI)
08:00Charlotte Rijsemus, Amsterdam / NL
6
The definition of a near-complete response after neoadjuvant (chemo)radiotherapy for rectal cancer: results of an expert survey
08:00Petra Custers, Amsterdam / NL
7
Prognostic models for classifying rectal tumour response to therapy using radiomics and CNN features
08:00Gisella Guido, Roma / IT
8
Added value of multiparametric PET/MRI in staging of rectal cancer
08:00Alexander Herold, Vienna / AT
9
Diffusion weighted MRI (DWI) and carbon ion radiotherapy (CIRT): a preliminary study on DWI predictive role in CIRT re-treatment of locally recurrent rectal cancer
08:00Dario Nicola Boccuzzi, Como / IT
10
Role of MRI for early tumour response evaluation in anal cancer after five weeks of chemoradiotherapy in guiding boost strategies
08:00Doenja Lambregts, Amsterdam / NL
